Related Experiment Video
Updated: Feb 15, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
Resource and cost considerations in treating hypoplastic left heart syndrome
Miguel Urencio1, Chris Greenleaf1, Jorge D Salazar2
1Division of Cardiothoracic Surgery.
Insights
Hypoplastic left heart syndrome (HLHS) treatment has dramatically improved survival rates since 1983. Advances in surgery, prenatal diagnosis, and intensive care have increased stage I survival to over 90%, though it remains resource-intensive.
Area of Science:
- Pediatric Cardiology
- Congenital Heart Surgery
- Neonatal Intensive Care
Background:
- Hypoplastic left heart syndrome (HLHS) was historically a fatal diagnosis.
- The Norwood I operation in 1983 marked the beginning of surgical intervention.
- Significant progress has been made in managing HLHS over the past decades.
Purpose of the Study:
- To review the surgical steps and outcomes for treating HLHS.
- To analyze the advancements contributing to improved survival rates.
- To compare the cost of HLHS treatment with simpler congenital heart defects.
Main Methods:
- Review of surgical techniques for HLHS treatment.
- Analysis of factors influencing operative survival rates.
- Comparative cost analysis of HLHS versus other congenital heart defects.
Main Results:
- Stage I operative survival for HLHS has increased from 53% to over 90%.
- Improvements are attributed to surgical advances, prenatal diagnosis, enhanced bypass technology, intensive care, and monitoring.
- Despite improved outcomes, HLHS management remains a significant challenge and resource burden.
Conclusions:
- Multidisciplinary teamwork and technological advancements have revolutionized HLHS outcomes.
- HLHS treatment requires substantial resources, posing a challenge for congenital heart programs.
- Further evaluation of cost-effectiveness compared to simpler defects is warranted.
Abstract:
Hypoplastic left heart syndrome (HLHS) was a uniformly fatal diagnosis before 1983, when surgical treatment was first undertaken with the Norwood I operation as the first of 3-staged operations. Since then, operative survival rate of stage I has risen from 53% to over 90% in the current era, not only thanks to technical advances in surgery but also through prenatal diagnosis and imaging, enhanced cardiopulmonary bypass technology, better perioperative intensive care, and closer interstage monitoring. The improvements in patient outcomes achieved through rigorous multidisciplinary teamwork have come at a tremendous cost in manpower and resources, making HLHS still a challenge to all congenital heart programs, established or emerging. We review the various surgical steps to treat HLHS and their current expected outcomes, and put into perspective cost considerations compared to other more "simple" congenital heart defects.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
Short-distance Transport of Resources
Anatomy of the Heart
Design Consideration
The factor of safety is another key...
Tensile Strength Considerations of Concrete
The dimensions and shape of a concrete specimen...
Transmission Line Design Considerations

